Brainomix Core Volume
See More. Do More. Save More.

Brainomix 360 unlocks expert-level insights from universally available non-contrast CT scans, helping stroke networks expand access to life-changing treatments.

The FDA-cleared core volume is a novel and patented feature that enables physicians to assess ischemic core volume from widely available non-contrast CT (NCCT) images through the Brainomix 360 Stroke solution.

The core volume feature has been studied and validated by leading US stroke centers, with results demonstrating equivalency to CT Perfusion and MRI-derived core volume assessments. This addresses a longstanding unmet need in stroke triage, enabling physicians across stroke networks to access expert-level insights to improve decision making for treatment and transfer of patients using routinely available brain scans.

New Webinar:
"Imaging the Core on NCCT: Unlocking Stroke Insights Across Networks"

RECORDING AVAILABLE

In this April 2025 webinar, Dr Mehdi Bouslama (Neuroendovascular Surgery & Vascular Neurology at Broward Health, Florida) and Dr Kambiz Nael (Professor of Neuroradiology at the University of California, San Francisco) discuss their experience with Brainomix Core Volume, with research results demonstrating equivalency to CT Perfusion and MRI-derived core volume assessments.

AI That Sees What Couldn't Be Seen Before

This key expansion of Brainomix 360 Stroke marks a critical advancement in stroke imaging and reinforces our mission to transform stroke care through cutting-edge technology. Brainomix 360 empowers stroke teams by unlocking real-time, high-precision insights that can help expand patient access to life-changing treatments, including both thrombolysis and mechanical thrombectomy, for use up to 24 hours after stroke onset.

From Imaging to Impact

Brainomix 360 is the only stroke AI imaging tool with a demonstrated impact on stroke treatment rates. Results from the largest real-world evaluation of stroke AI, incorporating national-level data from more than 450,000 patients over a 3-year period, found that Brainomix 360 was associated with a more than 50% increase in mechanical thrombectomy rates.

Elevating Stroke Care Across the US: The Brainomix Impact

CONTACT OUR TEAM

"Brainomix has the strategy to really make an impact in the US for stroke patients. It's our mission to get all patients access to expert-level care on a network-wide level," Brad Wittenberg.

"We are enabling access to stroke intervention, tripling the number of patients achieving functional recovery. We have validated results linked to treatment, not just time savings," Audrey Sheeley.

Learn More Here.